Clinical Trial: A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07153471) titled 'A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee' on Sept. 02.

Brief Summary: The GZPT master protocol will support two independent studies, J2A-MC-GZT1 and J2A-MC-GZT2. Each study will see how well and safely orforglipron works in people with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last about 74 weeks.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Osteoarthritis

Intervention: DRUG: Orforglipron

Administered orally

DRUG: Placebo

Administered orally

Recruitment Status: NOT...